[非单胺能神经元合成单胺:假象还是现实?]
[Synthesis of monoamines by non-monoaminergic neurons: illusion or reality?].
作者信息
Ugrumov Mikhail V
机构信息
Institut de Biologie du Développement, Académie Russe des Sciences et Institut de Physiologie Normale, Académie Russe des Sciences Médicales, 26 rue Vavilov, 117808 Moscou, Russie.
出版信息
J Soc Biol. 2009;203(1):75-85. doi: 10.1051/jbio:2009013. Epub 2009 Apr 10.
In contrast to monoaminergic (MA-ergic) neurons possessing the whole set of the enzymes for MA synthesis from the precursor amino-acid, some, mostly peptidergic, neurons co-express only one of the enzymes of monoamine synthesis. They are widely distributed in the brain, being particularly numerous in ontogenesis and, in adulthood, under certain physiological conditions. Most monoenzymatic neurons possess one of the enzymes for dopamine (DA) synthesis, tyrosine hydroxylase (TH) or aromatic L-amino acid decarboxylase (AADC). TH and AADC are enzymatically active in a substantial number of monoenzymatic neurons, where they are capable of converting L-tyrosine to L-3,4-dihydroxy-phenylalanine (L-DOPA) and L-DOPA to dopamine (DA) (or 5-hydroxy-tryptophan, 5-HTP to serotonin), respectively. According to our data L-DOPA synthesized in monoenzymatic TH-neurons is released and taken up by monoenzymatic AADC-neurons for DA synthesis. Moreover, L-DOPA captured by dopaminergic neurons and serotoninergic neurons serves to stimulate dopamine synthesis in the former and to start DA synthesis in the latter. Cooperative synthesis of MAs is considered as a compensatory reaction under a failure of MA-ergic neurons, e.g. in neurodegenerative diseases like hyperprolactinemia and Parkinson's disease, which are developed primarily because of degeneration of DA-ergic neurons of the tuberoinfundibular system and the nigrostriatal system, respectively. Noteworthy, the neurotoxin-induced increase of prolactin secretion returns with time to a normal level due to the stimulation of DA synthesis by the tuberoinfundibular most probably monoenzymatic neurons. The same compensatory mechanism is supposed to be used under the failure of the nigrostriatal DA-ergic system that is manifested by an increased number of monoenzymatic neurons in the striatum of animals with neurotoxin-induced parkinsonism and in humans with Parkinson's disease. Expression of the enzymes of MA synthesis in non-monoaminergic neurons is controlled by intercellular signals such as classical neurotransmitters (catecholamines), etc. Thus, a substantial number of brain neurons express partly the monoaminergic phenotype, namely individual complementary enzymes of MA synthesis, serving to produce MAs in cooperation, which is considered as a compensatory reaction under the failure of MA-ergic neurons.
与拥有从氨基酸前体合成单胺全套酶的单胺能(MA能)神经元不同,一些神经元(大多为肽能神经元)仅共表达单胺合成酶中的一种。它们广泛分布于大脑中,在个体发育过程中数量尤其众多,在成年期,在某些生理条件下也是如此。大多数单酶神经元拥有多巴胺(DA)合成酶中的一种,即酪氨酸羟化酶(TH)或芳香族L - 氨基酸脱羧酶(AADC)。TH和AADC在大量单酶神经元中具有酶活性,在这些神经元中它们能够分别将L - 酪氨酸转化为L - 3,4 - 二羟基苯丙氨酸(L - DOPA)以及将L - DOPA转化为多巴胺(DA)(或将5 - 羟色氨酸,5 - HTP转化为5 - 羟色胺)。根据我们的数据,在单酶TH神经元中合成的L - DOPA会被释放,并被单酶AADC神经元摄取用于DA合成。此外,多巴胺能神经元和5 - 羟色胺能神经元摄取的L - DOPA分别用于刺激前者的多巴胺合成以及启动后者的DA合成。单胺的协同合成被认为是MA能神经元功能衰竭时的一种代偿反应,例如在高催乳素血症和帕金森病等神经退行性疾病中,这些疾病主要分别是由于结节漏斗系统和黑质纹状体系统的多巴胺能神经元变性所致。值得注意的是,由于结节漏斗部很可能是单酶神经元对DA合成的刺激作用,神经毒素诱导的催乳素分泌增加会随着时间恢复到正常水平。在黑质纹状体多巴胺能系统功能衰竭时,推测也会采用相同的代偿机制,这表现为神经毒素诱导的帕金森病动物纹状体以及帕金森病患者纹状体中单酶神经元数量增加。非单胺能神经元中单胺合成酶的表达受细胞间信号如经典神经递质(儿茶酚胺等)控制。因此,大量脑神经元部分表达单胺能表型,即单胺合成的单个互补酶,用于协同产生单胺,这被认为是MA能神经元功能衰竭时的一种代偿反应。